You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Panniculitis

Showing 1 - 25 of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lipodystrophy Acquired, Type1diabetes Trial in Shanghai (Cyclophosphamide)

Recruiting
  • Lipodystrophy Acquired
  • Type1diabetes
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Jul 20, 2022

Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular T-Cell

Recruiting
  • Recurrent Angioimmunoblastic T-Cell Lymphoma
  • +13 more
  • Brentuximab Vedotin
  • Pembrolizumab
  • Chicago, Illinois
    Northwestern University
Jun 15, 2022

Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Trial in United States

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +14 more
  • Cholecalciferol
  • Laboratory Biomarker Analysis
  • Scottsdale, Arizona
  • +4 more
Jan 16, 2023

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
Has Results
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma

Recruiting
  • Anaplastic Large Cell Lymphoma
  • +19 more
  • Duarte, California
  • +2 more
Aug 15, 2022

LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

Recruiting
  • LGLL - Large Granular Lymphocytic Leukemia
  • +13 more
  • Duarte, California
  • +9 more
Aug 9, 2022

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T Cell Lymphoma, ALK-negative Anaplastic Large Cell

Unknown status
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • +5 more
  • CEOP/IVE/GDP chemotherapy regimen
  • CEOP chemotherapy regimen for 6 cycles
  • Fuzhou, Fujian, China
  • +3 more
Mar 7, 2020

Hyperemesis Gravidarum, Nausea Gravidarum, Vomiting of Pregnancy Trial (Capsaicin Topical Cream, Metoclopramide, Ondansetron)

Recruiting
  • Hyperemesis Gravidarum
  • +2 more
  • Capsaicin Topical Cream
  • +3 more
  • Providence, Rhode Island
    Women and Infants Hospital
Oct 17, 2022

Panniculitis Trial (panniculectomy)

Terminated
  • Panniculitis
  • panniculectomy
  • (no location specified)
Aug 13, 2018

Cutaneous Lupus Trial in Orlando (532nm laser, 1064nm laser, Topical corticosteroid)

Terminated
Has Results
  • Cutaneous Lupus
  • 532nm laser
  • +2 more
  • Orlando, Florida
    UCF Health Lake Nona Office
Jun 29, 2021

Cutaneous Lupus Erythematosus Trial (Anifrolumab, Placebo)

Not yet recruiting
  • Cutaneous Lupus Erythematosus
  • Anifrolumab
  • Placebo
  • (no location specified)
Aug 22, 2023

Relapsed or Refractory Peripheral T-Cell Lymphoma Trial in Korea, Republic of, Spain, United States (Tipifarnib)

Completed
  • Relapsed or Refractory Peripheral T-Cell Lymphoma
  • Palo Alto, California
  • +12 more
Apr 26, 2021

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Cancer Cachexia Trial (nutrition education)

Not yet recruiting
  • Cancer Cachexia
  • nutrition education
  • (no location specified)
Mar 1, 2022

Dermatosis Trial in Paris

Not yet recruiting
  • Dermatosis
    • Paris, France
      Service de gériatrie plaies et cicatrisation
    Oct 28, 2021

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New York (NY-ESO-1 OLP4, NY-ESO-1 OLP4 +

    Completed
    Has Results
    • Epithelial Ovarian Cancer
    • +2 more
    • NY-ESO-1 OLP4
    • +2 more
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Consecutive Abdominal MDCT Examinations WithMatched-pair

    Completed
    • Mesenteric Panniculitis
    • Review of multidetector row computed tomography scans
    • (no location specified)
    Oct 19, 2017

    Parkinson's Disease Trial in Worldwide (ND0612 (Levodopa/Carbidopa solution), ND0612 (Levodopa/Carbidopa solution) + morning

    Completed
    Has Results
    • Parkinson's Disease
    • ND0612 (Levodopa/Carbidopa solution)
    • ND0612 (Levodopa/Carbidopa solution) + morning oral IR-LD/CD
    • Chicago, Illinois
    • +10 more
    Feb 16, 2022

    Phenylketonuria Trial in United States (rAvPAL-PEG)

    Completed
    Has Results
    • Phenylketonuria
    • Aurora, Colorado
    • +13 more
    Sep 15, 2021

    Lipolysis Trial in New York (950 nm LED Device, 1050nm Diode Laser Device)

    Terminated
    Has Results
    • Lipolysis
    • 950 nm LED Device
    • 1050nm Diode Laser Device
    • New York, New York
      Sadick Research Group
    Oct 15, 2020

    Systemic Sclerosis, Scleroderma Trial in Worldwide (STI571)

    Completed
    Has Results
    • Systemic Sclerosis, Scleroderma
    • Chicago, Illinois
    • +6 more
    Jul 5, 2021

    Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Placebos)

    Active, not recruiting
    Has Results
    • Melanoma
    • Birmingham, Alabama
    • +209 more
    Nov 14, 2022

    Severity of Acute Pancreatitis

    Completed
    • Acute Pancreatitis
    • +2 more
      • Istanbul, Turkey
        Bezmialem Vakif University, Gastroenterology Clinic
      Apr 30, 2021

      Cancer, Melanoma Trial in Worldwide (Dabrafenib, Trametinib)

      Completed
      Has Results
      • Cancer
      • Melanoma
      • Guangzhou, Guangdong, China
      • +12 more
      Jan 4, 2022